, which causes tuberculosis disease, continues to be a major global health threat. Correct identification of valid drug targets is important for the development of novel therapeutics that would shorten the current 6-9 month treatment regimen and target resistant bacteria. Methionine aminopeptidases (MetAP), which remove the N-terminal methionine from newly synthesized proteins, are essential in all life forms (eukaryotes and prokaryotes).
View Article and Find Full Text PDFMycobacterium tuberculosis is a major health threat, necessitating novel drug targets. Protein synthesis in bacteria uses initiator tRNA charged with formylated methionine residue. Deletion of the formylase gene, tRNA-formyl transferase (fmt), causes severe growth-retardation in E.
View Article and Find Full Text PDF